Belhaven Biopharma | Finanzwire

Basculer en Français

11166	Companies
246602	Keywords
174550	Articles
133185	Press releases

Home
Companies
Belhaven Biopharma

BRIEF

published on 07/09/2024 at 17:05, 2 years 3 months ago

Belhaven Biopharma Study Shows Promising Results for Nasal Epinephrine Delivery

Belhaven Biopharma Nasdepi Anaphylaxis Treatment Medical Research Nasal Epinephrine
PRESS RELEASE

published on 07/09/2024 at 17:00, 2 years 3 months ago

New Canine Study From Belhaven Biopharma Supports Dry Powder Nasal Epinephrine Delivery Solution
Belhaven Biopharma presents promising results of Nasdepi Canine Study at Respiratory Drug Delivery 2024, indicating faster & effective treatment for anaphylaxis. Intranasal dry powder epinephrine offers breakthrough prospects in emergency care for severe allergies

Belhaven Biopharma Anaphylaxis Treatment Nasdepi Canine Study Dry Powder Nasal Solution Respiratory Drug Delivery 2024
PRESS RELEASE

published on 02/08/2024 at 18:30, 2 years 8 months ago

Belhaven Biopharma Announces Groundbreaking Clinical Results for Nasdepi, the Revolutionary Nasal Dry Powder Epinephrine Product
Belhaven Biopharma shares positive results from Phase 1 clinical trial of Nasdepi, a nasal dry powder epinephrine device for treating anaphylaxis. Successful investor round and Series A financing on the horizon

Phase 1 Clinical Trial Series A Financing Belhaven Biopharma Nasdepi Anaphylaxis Treatment
PRESS RELEASE

published on 11/28/2023 at 19:30, 2 years 10 months ago

Belhaven Biopharma Achieves Significant Milestones in Advancing Nasdepi - a Revolutionary Nasal Dry Powder Epinephrine Product

Accesswire

Published on 10/13/2026 at 15:00, 18 minutes ago

Reminder: Today, October 13, 2026, is the Record Date for Jaguar Health's Special Stock Dividend
Published on 10/13/2026 at 14:45, 33 minutes ago

Phase II Clinical Trial of NV-387 Oral Gummies as Treatment of Ebola Progressing Well, Says NanoViricides
Published on 10/13/2026 at 14:31, 47 minutes ago

First Breach Completes First Autonomous Flight of Proprietary Drone Prototype
Published on 10/13/2026 at 14:10, 1 hour 8 minutes ago

NioCorp Places 100% of Its Planned Critical Minerals Production Under Commercial Sales Agreements
Published on 10/13/2026 at 14:00, 1 hour 18 minutes ago

Orogen Royalties Enters into Agreement to Sell the Slaughterhouse Copper-Gold Project to Seabridge Gold

View all ACCESSWIRE

EQS Group

Published on 10/13/2026 at 15:06, 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 10/13/2026 at 15:05, 13 minutes ago

Form 8.3 - The Vanguard Group, Inc.: RHI Magnesita N.V.
Published on 10/13/2026 at 15:05, 13 minutes ago

Graylog v7.2 launches the Verascend™ Incident System, transforming how security teams detect and respond to threats
Published on 10/13/2026 at 15:03, 14 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc
Published on 10/13/2026 at 15:02, 16 minutes ago

Form 8.3 - The Vanguard Group, Inc.: DCC plc

Les Echos

Published on 10/13/2026 at 09:04, 6 hours 14 minutes ago

Peru Is Recognized as “South America's Leading Destination” at the World Travel Awards
Published on 10/12/2026 at 17:59, 21 hours 19 minutes ago

Reporting on share buyback transactions carried out between October 7 and October 9, 2026
Published on 10/12/2026 at 17:45, 21 hours 33 minutes ago

Weekly share buyback
Published on 10/12/2026 at 17:45, 21 hours 33 minutes ago

Declaration of transactions on own shares from October 5, 2026 to October 11, 2026
Published on 10/12/2026 at 15:47, 23 hours 31 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of September 30, 2026

View all LES ECHOS COMFI WIRE